{
  "success": true,
  "pagesUsed": [],
  "modelUsed": "unknown",
  "amendmentdetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 1.3 Schedule of Activities (SoA), Table 1",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added footnote regarding procedures specific to US screening sites."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 4.2 Scientific Rationale for Study Design",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Updated the duration of zinc inhibitory effects on intestinal copper absorption."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 8 Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Introduced US-specific provision allowing sites to perform only screening procedures without subsequent study procedures."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To facilitate participant recruitment across different regions of the US and lessen inconvenience for participants without compromising study quality.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To align the number of days for zinc discontinuation effects with mentions elsewhere in the protocol.",
        "category": "Administrative",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3.1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Procedures specific to screening sites (only in the US) detailed in Section 8",
        "summary": "Added footnote to SoA Table 1 regarding US screening sites."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3.1_US",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "minimal 30 days after discontinuation of zinc",
        "afterText": "minimal 21 days after discontinuation of zinc",
        "summary": "Reduced the expected duration of zinc's inhibitory effect from 30 to 21 days."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3.1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Addition of text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "Added provision for US-based screening-only sites."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 2,
      "changeCount": 3
    }
  }
}